TH023

TH023 is a small molecule inhibitor that selectively disrupts TLR4 homodimerization, blocking downstream NF-κB activation and inflammatory cytokine production. It demonstrates potent anti-inflammatory activity in cellular assays and in vivo models, including LPS-induced sepsis and acute lung injury, making it a valuable research tool for studying innate immunity and inflammation-related diseases.